HOME > December 19, 2022
Daily News
December 19, 2022
- Healthcare Providers Rap Product Coverage of Off-Year Re-Pricing, Payers Hail Threshold: Chuikyo
December 19, 2022
- R&D Head Shiro Akinaga Becomes NanoCarrier President
December 19, 2022
- SymBio, Eagle Pharma Sue Towa over Treakisym Patent in Japan
December 19, 2022
- Sosei, Lilly in Drug Discovery Collab for Diabetes and Metabolic Diseases
December 19, 2022
- Astellas’s Zolbetuximab Makes Marks in Another PIII Gastric Cancer Study
December 19, 2022
- Japan Citizen’s Group Opposes NIP Inclusion of Silgard 9
December 19, 2022
- Orphan Drug Tag Granted for Takeda’s Maralixibat and More
December 19, 2022
- Pharma Industry Mixed on Off-Year Drug Price Revision Plan for FY2023
December 19, 2022
- Ruling Parties OK FY2023 Tax Reform Outline; No More Special COVID Measure for R&D Credits
December 19, 2022
- Chuikyo OKs FY2023 Price Revision Outline Specifying “0.625 Times” Product Coverage Threshold
December 19, 2022
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
